申请人:Stauderman Kenneth A.
公开号:US20140187616A1
公开(公告)日:2014-07-03
Described herein are compositions and uses thereof related to Ca
2+
release-activated Ca
2+
(CRAC) channel activity. Also described herein CRAC channel modulators for treating diseases or conditions that would benefit from inhibition of SOC channel activity.